0649 GMT - Bayer's results should lead to a positive share price response after the company posted better-than-expected earnings and reiterated its outlook, Jefferies analysts say in a note. The German pharmaceutical and agricultural company now forecasts its outlook for the pharma division at the upper end of its guidance range, the analysts say. Its 1Q earnings and sales topped company-compiled and Jefferies' consensus, they say. (helena.smolak@wsj.com)
(END) Dow Jones Newswires
May 13, 2025 02:50 ET (06:50 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。